Keyphrases
Paclitaxel Chemotherapy
100%
Cisplatin-based Chemotherapy
100%
Chemotherapy Response Assay
100%
Adenosine Triphosphate
100%
Individualized Tumor Response Testing
100%
Response Prediction
100%
Positive Predictive Value
20%
WHO Criteria
20%
Negative Predictive Value
20%
ROC Analysis
20%
Chemosensitivity
20%
Metastatic Gastric Cancer
20%
Validation Studies
20%
Chemosensitive
20%
Indexing Methods
20%
In Vitro Chemosensitivity
20%
Gastric Cancer Patients
20%
Chemoresistant
20%
Study Support
20%
Prospective Clinical Trial
20%
Patient Response
20%
Locally Advanced Gastric Cancer
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Cisplatin
100%
Paclitaxel
100%
Chemotherapy
100%
Stomach Cancer
100%
Adenosine Triphosphate
62%
Progression Free Survival
12%
Overall Survival
12%
Clinical Trial
12%
Nursing and Health Professions
Cisplatin
100%
Stomach Cancer
100%
Adenosine Triphosphate
100%
Standard
20%
Progression Free Survival
20%
Combination Chemotherapy
20%
Positive and Negative Predictive Values
20%
Neuroscience
Adenosine Triphosphate
100%
Paclitaxel
100%
Medicine and Dentistry
Stomach Cancer
100%
Chemosensitivity
40%
Biochemistry, Genetics and Molecular Biology
Chemosensitivity
40%
Progression Free Survival
20%